|1.||Jáuregui, I: 5 articles (01/2011 - 04/2010)|
|2.||Bartra, J: 4 articles (01/2011 - 01/2011)|
|3.||Dávila, I: 4 articles (01/2011 - 01/2011)|
|4.||Ferrer, M: 4 articles (01/2011 - 01/2011)|
|5.||Montoro, J: 4 articles (01/2011 - 01/2011)|
|6.||Mullol, J: 4 articles (01/2011 - 01/2011)|
|7.||Valero, A: 4 articles (01/2011 - 01/2011)|
|8.||Sastre, J: 4 articles (01/2011 - 01/2011)|
|9.||Mullol, Joaquim: 3 articles (08/2013 - 01/2012)|
|10.||Valiente, R: 3 articles (05/2013 - 09/2009)|
06/18/2012 - "In another well designed phase III trial, compared with placebo, bilastine was associated with a significantly greater change from baseline to day 28 in the mean reflective daily urticaria symptom score in patients with chronic urticaria. "
12/01/2012 - "In addition, bilastine has proved to be effective for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. "
01/01/2011 - "Bilastine is a new H1 antihistamine that proves to be effective in treating allergic rhinoconjunctivitis (seasonal and perennial) and urticaria. "
09/01/2011 - "Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria."
07/01/2013 - "Increased efficacy of bilastine with fourfold up-dosing was without sedation and supports urticaria treatment guidelines."
07/01/2014 - "Bilastine is a novel H1 antihistamine with anti-allergic properties which is highly effective in the treatment of symptoms of allergic rhinitis. "
07/01/2014 - "Bilastine as a potential treatment in allergic rhinitis."
01/01/2012 - "Bilastine meets current EAACI/ARIA criteria for medications used in the treatment of allergic rhinitis."
01/01/2012 - "The optimal properties of oral H(1)-antihistamines and current ARIA recommendations for their use in allergic rhinitis are presented, as well as relevant pharmacological and clinical data for bilastine obtained from the published literature that specifically address the defined criteria. "
01/01/2012 - "Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review."
|3.||Seasonal Allergic Rhinitis (Hay Fever)
06/18/2012 - "Additionally, reflective nasal symptom scores were significantly lower in bilastine than placebo recipients in patients with a history of seasonal allergic rhinitis who were challenged with grass pollen allergen in a single-centre, phase II study. "
06/18/2012 - "In two well designed phase III trials, 14 days' treatment with bilastine was associated with a significantly lower area under the effect curve (AUEC) for the reflective total symptom score (TSS) than placebo in patients with symptomatic seasonal allergic rhinitis. "
01/01/2012 - "Bilastine is a non-sedating second-generation H(1) antihistamine with proven efficacy and safety in the treatment of patients with seasonal allergic rhinitis and urticaria. "
09/01/2009 - "Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study."
01/01/2009 - "The objective of this study was to compare the efficacy and safety of bilastine 20 mg vs placebo and desloratadine 5 mg in subjects with seasonal allergic rhinitis (SAR). "
|4.||Perennial Allergic Rhinitis
01/01/2012 - "The objective of this study was to demonstrate the efficacy and safety of bilastine in patients with perennial allergic rhinitis (PAR). "
06/18/2012 - "Neither bilastine nor cetirizine was effective in the treatment of perennial allergic rhinitis with regard to the mean AUEC for reflective TSS in another well designed phase III trial. "
01/01/2012 - "Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis."
01/01/2011 - "The present review examines the effect of bilastine, a new, potent and highly specific H1 antihistamine without sedative effects or cardiac toxicity, upon nasal obstruction. "
01/01/2011 - "Effect of bilastine upon nasal obstruction."
01/01/2011 - "The analysis of the data from the different clinical trials indicates that in patients with allergic rhinitis, the effect of bilastine upon nasal obstruction is superior to that of placebo and similar to that of other second-generation H1 antihistamines, manifesting within 24 hours after the start of treatment."
|3.||Histamine Antagonists (Antihistamines)
|9.||Histamine (Histamine Dihydrochloride)
|10.||Phosphodiesterase 4 Inhibitors